Clinical manifestation, prognosis and treatment of follicular lymphoma / 白血病·淋巴瘤

ABSTRACT

Follicular lymphoma accounts for 22.1% of non-Hodgkin lymphoma. It is an indolent lymphoma. The clinical feature is lymphadenopathy with/without marrow involvement. The prognostic factors include follicular lymphoma international prognosis index (FLIPI) and tumor infiltrating immune cells. The fast-line therapy is immunochemotherapy with rituximab. In patients with refractory/refapes disease, stem cell transplantation is the choice.